CLINICAL TRIALS PROFILE FOR ESTROGENS, CONJUGATED SYNTHETIC B

« Back to Dashboard

All Clinical Trials for estrogens, conjugated synthetic b

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00006133 ↗	Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus	Completed	University of Alabama at Birmingham	N/A	2000-06-01	OBJECTIVES: I. Determine the effect of oral contraceptives containing low-dose synthetic estrogens and progestins on disease activity in premenopausal women with inactive, stable, or moderate systemic lupus erythematosus (SLE). II. Determine the effect of hormone replacement therapy with conjugated estrogens and progestins on disease activity in postmenopausal women with inactive, stable, or moderate SLE.
NCT00006133 ↗	Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus	Completed	National Center for Research Resources (NCRR)	N/A	2000-06-01	OBJECTIVES: I. Determine the effect of oral contraceptives containing low-dose synthetic estrogens and progestins on disease activity in premenopausal women with inactive, stable, or moderate systemic lupus erythematosus (SLE). II. Determine the effect of hormone replacement therapy with conjugated estrogens and progestins on disease activity in postmenopausal women with inactive, stable, or moderate SLE.
NCT00196378 ↗	A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy	Completed	Duramed Research	Phase 3	2004-11-01	This is a two-arm, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy of Enjuvia 0.3 mg tablets for the treatment of moderate to severe symptoms of vulvovaginal atrophy in postmenopausal women with or without a hysterectomy and/or oophorectomy.

Clinical Trial Conditions for estrogens, conjugated synthetic b

Condition Name

Condition Name for estrogens, conjugated synthetic b
Intervention	Trials
Menopause	2
Hot Flashes	1
Nocturnal Vasomotor Symptoms	1

Condition MeSH

Condition MeSH for estrogens, conjugated synthetic b
Intervention	Trials
Atrophy	2
Hot Flashes	1
Lupus Erythematosus, Systemic	1

Clinical Trial Locations for estrogens, conjugated synthetic b

Trials by Country

Trials by Country for estrogens, conjugated synthetic b
Location	Trials
United States	98
Australia	1

Trials by US State

Trials by US State for estrogens, conjugated synthetic b
Location	Trials
Texas	5
Pennsylvania	5
California	5
Florida	4
North Carolina	4

Clinical Trial Progress for estrogens, conjugated synthetic b

Clinical Trial Phase

Clinical Trial Phase for estrogens, conjugated synthetic b
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	3
Phase 2	1

Clinical Trial Status

Clinical Trial Status for estrogens, conjugated synthetic b
Clinical Trial Phase	Trials
Completed	6

Clinical Trial Sponsors for estrogens, conjugated synthetic b

Sponsor Name

Sponsor Name for estrogens, conjugated synthetic b
Sponsor	Trials
Duramed Research	4
University of Alabama at Birmingham	1
National Center for Research Resources (NCRR)	1

Sponsor Type

Sponsor Type for estrogens, conjugated synthetic b
Sponsor	Trials
Industry	4
Other	3
NIH	1